Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
'Status Quo' on Different Aspects of Gender Distribution in Rheumatology in Germany-Results from a Nationwide Online Survey among Physicians.
Ohrndorf S, Krusche M, Baraliakos X, Feist E, Gundelach B, Haase I, Hoyer BF, Kiltz U, Koehm M, Voormann AJ, Sewerin P, Mucke J; Commission for ‘Gender Equity in Rheumatology’ from the German Society for Rheumatology. Ohrndorf S, et al. Among authors: koehm m. J Clin Med. 2023 Jun 27;12(13):4328. doi: 10.3390/jcm12134328. J Clin Med. 2023. PMID: 37445363 Free PMC article.
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies.
Koehm M, McIntosh MJ, Hofmann MW, Abraham V, Gabay C, Choy EH, Kavanaugh A, Burkhardt H, Behrens F. Koehm M, et al. Rheumatol Int. 2020 May;40(5):747-755. doi: 10.1007/s00296-020-04514-7. Epub 2020 Feb 10. Rheumatol Int. 2020. PMID: 32040761
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA).
Koehm M, Foldenauer AC, Rossmanith T, Alten R, Aringer M, Backhaus M, Burmester GR, Feist E, Kellner H, Krueger K, Müller-Ladner U, Rubbert-Roth A, Tony HP, Wassenberg S, Burkhardt H, Behrens F. Koehm M, et al. J Clin Med. 2022 Dec 9;11(24):7316. doi: 10.3390/jcm11247316. J Clin Med. 2022. PMID: 36555933 Free PMC article.
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up.
Koehm M, Ohrndorf S, Foldenauer AC, Rossmanith T, Backhaus M, Werner SG, Burmester GR, Wassenberg S, Koehler B, Burkhardt H, Behrens F. Koehm M, et al. RMD Open. 2022 Dec;8(2):e002682. doi: 10.1136/rmdopen-2022-002682. RMD Open. 2022. PMID: 36597973 Free PMC article.
An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis.
Watson L, Coyle C, Whately-Smith C, Brooke M, Kiltz U, Lubrano E, Queiro R, Trigos D, Brandt-Juergens J, Choy E, D'Angelo S, Delle Sedie A, Dernis E, Guis S, Helliwell P, Ho P, Hueber AJ, Joven B, Koehm M, Montilla C, Packham J, Pinto Tasende JA, Ramirez Garcia FJ, Ruyssen-Witrand A, Scrivo R, Twigg S, Soubrier M, Wirth T, Gossec L, Coates LC. Watson L, et al. Among authors: koehm m. Rheumatology (Oxford). 2023 Nov 27:kead621. doi: 10.1093/rheumatology/kead621. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38011669
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).
Behrens F, Koehm M, Rossmanith T, Alten R, Aringer M, Backhaus M, Burmester GR, Feist E, Herrmann E, Kellner H, Krueger K, Lehn A, Müller-Ladner U, Rubbert-Roth A, Tony HP, Wassenberg S, Burkhardt H. Behrens F, et al. Among authors: koehm m. Rheumatology (Oxford). 2021 Nov 3;60(11):5318-5328. doi: 10.1093/rheumatology/keab153. Rheumatology (Oxford). 2021. PMID: 33738492 Free PMC article. Clinical Trial.
Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab.
Schmalzing M, Behrens F, Schwaneck EC, Koehm M, Greger G, Gnann H, Burkhardt H, Tony HP. Schmalzing M, et al. Among authors: koehm m. Medicine (Baltimore). 2020 May;99(19):e20201. doi: 10.1097/MD.0000000000020201. Medicine (Baltimore). 2020. PMID: 32384515 Free PMC article.
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study.
Koehm M, Klippstein M, Dauth S, Hallmann K, Kohmer N, Burkhardt H, Ciesek S, Geisslinger G, Rabenau HF, Behrens F. Koehm M, et al. RMD Open. 2023 Aug;9(3):e003094. doi: 10.1136/rmdopen-2023-003094. RMD Open. 2023. PMID: 37652553 Free PMC article.
29 results